ProPhase - PRPH Net earnings per share for the last four quarters
Declining post-pandemic diagnostic demand and genomics expenditures create profit risks for ProPhase Labs, Inc. (PRPH). The trailing twelve months (TTM) net income per share growth rate visualizes this margin of safety, where this metric equals -141.70. Brand stability in molecular testing and the implementation of ESG standards for biohazardous waste disposal support the market positions of ProPhase Labs, Inc. (PRPH).
PRPH (ProPhase): analytical breakdowns and indicator data
- market price and analyst price targets:
- issuer market value details:
- book value of equity indicators:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio ProPhase Labs, Inc.|PRPH - Long-Term Debt to Equity|Current Liabilities to Capital ProPhase Labs Corp|PRPH - Company Debts|Debts to Book Capitalization Ratio ProPhase Labs Inc|PRPH - Company Long-Term Debts|Company Short-Term Loans and Borrowings ProPhase Labs|Quick Ratio prophaselabs.com
- business earnings and investment ratios data:
PRPH - Company Net Income|Company Profit Forecast ProPhase Labs, Inc.|PRPH - P/E Multiple|Projected Price to Earnings Ratio ProPhase Labs Inc|PRPH - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation ProPhase Labs Inc|PRPH - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months ProPhase Labs|PRPH - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth prophaselabs.com|PRPH - Earnings growth in current year|Net earnings per share growth forecast for next year ProPhase Labs, Inc.
Initial company analysis:prophaselabs.com
This indicator measures the dynamics of net earnings per share over the last twelve months relative to the same period last year, allowing for the filtering of short-term fluctuations to assess real profitability. By analyzing the current EPS YoY TTM growth rate, a conservative investor can determine the effectiveness of ProPhase Labs, Inc. (PRPH) and its strategic transition toward scaling genetic testing and commercializing therapeutic products in the post-pandemic era.
Competitor analysis for ProPhase Labs, Inc.
Net earnings per share for the last four quarters agilent.com A|DGX: Net earnings per share (EPS TTM)|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cologuard|Revvity Corp (RVTY) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Bio-Rad Laboratories (BIO)|NNNN: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Sotera Health SHC|Earnings per share for the trailing year QDEL|OPK - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months CareDx, Inc|Maravai LifeSciences (MRVI) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months FLGT (fulgentgenetics.com)|LAB (Standard BioTools) - Net earnings per share (EPS TTM)|CTKB: Earnings per share for the trailing year|Net earnings per share (EPS TTM) OSUR|Net earnings per share (EPS TTM) exagen.com (XGN)|Earnings per share for the last twelve months MDxHealth SA MDXH|Net earnings per share for the last four quarters luciddx.com (LUCD)|Prenetics Global Ltd - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insight Molecular Diagnostics|TRIB (trinitybiotech.com) - Net earnings per share for the last 12 months|Ainos Corporation - Earnings per share for the trailing year|Earnings per share for the last twelve months Co-Diagnostics, Inc.|Earnings per share for the last twelve months HSCS|Net earnings per share (EPS TTM) BMRA|Net earnings per share (EPS TTM) cardiodiagnosticsinc.com (CDIO)|Net earnings per share (EPS TTM) ONCO (Onconetix Corp)|Virax Biolabs Corp - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters aspirawh.com AWH|AXDX (Accelerate Diagnostics, Inc.) - Net earnings per share for the last 12 months|centogene.com - Earnings per share for the trailing year|ENZ (Enzo Biochem Inc.) - Net earnings per share (EPS TTM)|Fresh2 (FRES) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Genetic Technologies (GENE)|23andme.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) PMD (Psychemedics Corporation)
